-
Product Insights
NewI-calQ LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our I-calQ LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. I-calQ LLC (I-calQ) smartphone-based thyroid disease management using point-of-care TSH measurement that includes point-of-care HIV, syphilis, glucose, blood pressure, hemoglobin, and urinary albumin measurements to provide standard antenatal screening. I-calQ is headquartered in Scottsdale, Arizona, the US. GlobalData's Medical Devices company profile report, “I-calQ LLC Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on...
-
Product Insights
NewI-Sens Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our I-Sens Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. I-Sens Inc (I-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise blood glucose monitors, point of care devices, veterinary care devices and accessories. It provides its blood monitoring systems for personal and hospital use. I-SENS’ accessories comprise control solutions, lancing devices, and blood glucose data management software products, among others. It...
-
Company Insights
NewBoditech Med Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Boditech Med Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Boditech Med Inc (Boditech) is a medical device company that manufactures and distributes in-vitro diagnostic analyzers and reagents. The company’s products include ichroma Reader, AFIAS-6, IVD test device and i-chamber. It also offers diagnostics systems to test various diseases including diabetes, cardiac diseases, cancers, infection diseases and hormonal disorders, cardiac, cancer, covid-19 test kit, autoimmune, organ function, molecular diagnostics...
-
Product Insights
NewNOWDiagnostics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our NOWDiagnostics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. NOWDiagnostics Inc (NOWDiagnostics) is a medical diagnostic company. It manufactures and sells blood-based rapid tests. The company offers COVID-19 test, acetaminophen test, hCG test, H-FABP test, methanol dip test, salicylate test, troponin I test, myoglobin test, in home HIV test, and others. NOWDiagnostics’ additional tests are in the development pipeline including sexually transmitted diseases, food intolerances, common infectious diseases, and...
-
Product Insights
NewDaxor Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Daxor Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Daxor Corp (Daxor) is a biotechnology company, which offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. It finds application in a range of medical...
-
Product Insights
NewAlmac Diagnostic Services Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Almac Diagnostic Services Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Almac Diagnostic Services Ltd (Almac Diagnostic Services), a subsidiary of Almac Group Ltd, is a medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company provides products pipeline such as ColDx, DDRD, AADx, prostate Dx and MEK Dx, among others. It offers ColDx, a prognostic assay for stage II and III colon cancer,...
-
Product Insights
NewQuarterly Herbs, Spices & Seasonings pricing trends in Japan
Empower your strategies with our Quarterly Herbs, Spices & Seasonings pricing trends in Japan report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ambroxol in Gaucher Disease Type I
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ambroxol in Gaucher Disease Type I report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ambroxol in Gaucher Disease Type I Drug Details: Ambroxol (BEL-0218)...
-
Product Insights
NewQuarterly Still Wine pricing trends in the United Kingdom
Empower your strategies with our Quarterly Still Wine pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ambroxol in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ambroxol in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ambroxol in Parkinson's Disease Drug Details: Ambroxol (BEL-0218) is under development for...